Bausch Health (BHC)
(Delayed Data from NYSE)
$8.53 USD
+0.17 (2.03%)
Updated Jul 1, 2022 04:00 PM ET
5-Strong Sell of 5 5
A Value C Growth A Momentum A VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
BHC 8.53 +0.17(2.03%)
Will BHC be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for BHC based on the 1-3 month trading system that nearly triples the S&P 500.
Zacks News for BHC
Bausch (BHC) Suspends IPO Plans for Solta Medical
Why Is Bausch (BHC) Down 11.2% Since Last Earnings Report?
BHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Implied Volatility Surging for Bausch (BHC) Stock Options
New Strong Sell Stocks for May 19th
Bausch (BHC) Q1 Earnings and Revenues Miss, Stock Down
Other News for BHC
BHC August 12th Options Begin Trading
Bausch Health Stock: Why There are Better Opportunities Elsewhere
NIO Stock Falls as Grizzly Research Targets the EV Maker in New Short Report
Bausch Health Stock Soared By 20%: What To Do Now
Bausch Health call volume above normal and directionally bullish